Contact
Please use this form to send email to PR contact of this press release:
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use
TO:
Please use this form to send email to PR contact of this press release:
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use
TO: